Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/acem.14982 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Response to letter regarding "A pilot trial exploring the use of music in the emergency department and its association with delirium and other clinical outcomes".
Emerg Med Australas
April 2025
UNSW Sydney, Sydney, New South Wales, Australia.
3D Model of Human Epidermis Exposed to Staphylococci Reveals Keratinocyte Responses Unique to Atopy-Associated S. aureus Challenge.
Allergy
March 2025
Department of Immunology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
Response on Rapid Review to Inform Policy Guidance on Welsh Respiratory ECMO Provision.
Semin Cardiothorac Vasc Anesth
March 2025
Adult Critical Care Directorate, Cardiff and Vale University Health Board, Cardiff, UK.
Internationally, extracorporeal membrane oxygenation (ECMO) is now a core and standard organ support tool to provide tertiary critical care and cardiac services within a network of hospitals and a key tool for running an effective and efficient cardio-respiratory pathways. The letter aims to put the spotlight on some of the missing clinical evidence on respiratory ECMO and including them will help to arrive at a better-informed national ECMO policy decision.
View Article and Find Full Text PDFEfficacy and safety of immune checkpoint inhibitors in metastatic penile squamous cell carcinoma: a retrospective multicenter analysis.
Exp Hematol Oncol
March 2025
The University of Kansas Cancer Center, 2650 Shawnee Mission Pkwy, Westwood, KS, 66205, United States of America.
Penile squamous cell carcinoma (PSCC) is a rare malignancy, and first-line therapy typically involves cisplatin-based chemotherapy. However, these regimens are often unsuitable for patients with poor performance status or advanced age due to their toxicity. This retrospective, multicenter study evaluated patients with metastatic PSCC who received immune checkpoint inhibitor (ICI) therapy between 2017 and 2024.
View Article and Find Full Text PDFExosomal PD-L1 and lactate versus tissue PD-L1 as biomarkers for clinical outcomes of PD-1 Blockade plus chemotherapy in metastatic esophagogastric signet ring cell carcinoma.
Exp Hematol Oncol
March 2025
Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China.
In this investigator-initiated, prospective, exploratory study, biomarkers predictive of clinical outcomes of first-line immune checkpoint inhibitor (ICI, nivolumab or pembrolizumab) plus XELOX(oxaliplatin and capecitabine) were identified in human epidermal growth factor receptor 2 (HER2)-negative patients with metastatic esophagogastric signet ring cell carcinoma. The findings showed an objective response rate (ORR) of 51.5% and a disease control rate of 86.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!